ISG revenues soar to new heights

Article

Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer

Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer reported a 30% increase in revenues and a 250% increase in earnings for its fiscal year (end-June 30). Revenues were $32 million (U.S.) in fiscal 1999, up from $24.3 million in fiscal 1998. The company had earnings of $1.2 million, compared with $336,500 last year. Revenues for the quarter were $9.8 million, compared with $6.8 million for the fourth quarter a year ago. Profits for the quarter were $608,000, compared with $135,000 for the same period in 1998.

ISG realized earnings increases in all three of its business units (image management, diagnostic imaging, and image-guided surgery), plus a 62% rise in software license fee generation, according to CEO Michael Greenberg. The enhanced penetration of ISG’s Image Application Platform software in healthcare accounts for the increase in licensing fees, according to ISG.

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.